Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.3792
-0.0581 (-13.29%)
Oct 13, 2026, 2:48 PM EDT - Market open
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $71.25 million as of October 13, 2026. It is the 26,784th most valuable company in the world and the 4,289th biggest in the United States. Its market cap has decreased by 76.72% in one year.
Market Cap
71.25M
Enterprise Value
7.67M
1-Year Change
-76.72%
Global Rank
Country Rank
#4,289 United States
Category
ChartMarket Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $71.25M, a decrease of -97.24%. That is a compound annual growth rate of -68.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 71.25M | -76.58% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 95.16M |
| Cellectis | 91.82M |
| Rallybio | 90.38M |
| Equillium | 89.41M |
| ImmuCell | 89.01M |
| NeurAxis | 87.03M |
| ProMIS Neurosciences | 86.18M |
| Cardiff Oncology | 84.02M |